Daily BriefsEvent-Driven

Daily Brief Event-Driven: [Japan Event] Sony Financial Spin-Off Trades Monday – Fina(Ncia)L Thoughts and more

In today’s briefing:

  • [Japan Event] Sony Financial Spin-Off Trades Monday – Fina(Ncia)L Thoughts
  • Waaree Energies Under US Scrutiny: A Solar Powerhouse Faces Tariff Probe
  • Chorus Aviation’s Odd Lot Tender Offers Potential C$45 Upside for Tax-Exempt Investors Amid Share Buyback


[Japan Event] Sony Financial Spin-Off Trades Monday – Fina(Ncia)L Thoughts

By Travis Lundy

  • Today is the last day of trading for Sony Corp (6758 JP) with Sony Financial Group (8729 JP) spin-off rights. SFGI starts trading separately on Monday 29 Sep.
  • The reference price is ¥150/share. It will likely stay in all major indices except Nikkei 225, and it likely needs low ¥160s to stay in M _ _ _. 
  • The estimated Div Yield is higher on SFGI than peers by a fair ways, and looks to grow, and there is a big buyback to come. I like it.

Waaree Energies Under US Scrutiny: A Solar Powerhouse Faces Tariff Probe

By Nimish Maheshwari

  • The U.S. Customs and Border Protection (CBP) has launched a formal investigation into Waaree Energies, alleging the company evaded anti-dumping and countervailing duties by mislabeling Chinese-made solar products as Indian.  
  • The probe, initiated by a U.S. domestic manufacturing coalition, directly threatens India’s growing solar exports to the U.S. and highlights the complexities of global supply chains.
  • This investigation introduces significant regulatory and financial risk for Waaree Energies, and the outcome will be a crucial for its ability to participate in the U.S. market.

Chorus Aviation’s Odd Lot Tender Offers Potential C$45 Upside for Tax-Exempt Investors Amid Share Buyback

By Special Situation Investments

  • Chorus Aviation is repurchasing 8% of shares at C$23.00–C$25.00, with odd-lot holders prioritized.
  • Paid-up capital is C$15.75/share; amounts above this are treated as dividends, impacting tax-exempt accounts.
  • Previous tender was undersubscribed; CHR shares viewed as undervalued, with historic low EBITDA multiples.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars